>While we are looking at the bad debts in relation to NTR, a funder would be looking at the total transactions.
Exactly, because that's what matters.
There are a lot of complaints about management as it relates to funding, but it would be decidedly poor management to take a bad funding deal out of deference to shareholders. Sure they could probably get funding right now but at what cost? Likely a longer contract at a higher interest rate. Not a good deal.
>The increase in staff does make me think that they must be anticipating funding to become available soon in my opinion.
This isn't a strict BNPL company, they have need for other staff to do stuff.
Why does a BNPL company need IDSB MORE than they need 21 million dollars for funding BNPL? That makes no sense.
https://govinsider.asia/digital-economy/how-this-tool-is-helping-malaysia-towards-a-cashless-government-omran-bin-omar-muhamad-shukri-bin-ramli-kpkt/#:~:text=Malaysia%20in%20particular%20is%20working,public%20sector%20reach%20this%20goal.
This is why. Time is of the essence for IOU.
- Forums
- ASX - By Stock
- OVT
- Pinelabs IPO Leaves IOU for Dust
Pinelabs IPO Leaves IOU for Dust, page-23
-
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OVT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.3¢ |
Change
-0.008(19.5%) |
Mkt cap ! $73.08M |
Open | High | Low | Value | Volume |
4.3¢ | 4.4¢ | 3.1¢ | $5.939M | 163.1M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1310576 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 4545813 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 2504930 | 0.032 |
23 | 6045130 | 0.031 |
28 | 3086501 | 0.030 |
15 | 3775931 | 0.029 |
14 | 2035643 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 389231 | 4 |
0.034 | 4545813 | 14 |
0.035 | 4111389 | 10 |
0.036 | 4785650 | 13 |
0.037 | 8902783 | 8 |
Last trade - 13.01pm 13/11/2024 (20 minute delay) ? |
Featured News
OVT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online